Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ian Garrahy"'
Publikováno v:
Life, Vol 14, Iss 8, p 953 (2024)
Coronavirus disease of 2019 (COVID-19) is the respiratory viral infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite being a primary respiratory illness, it is commonly complicated by systemic involvement of t
Externí odkaz:
https://doaj.org/article/950dfec3026145858001654ce5e55a51
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 10, Iss 6, Pp 600-603 (2020)
Introduction Mycophenolate Mofetil (MMF), although a widely used immunosuppressant; an increasing concern of MMF induced Primary Central Nervous System Lymphoma (PCNSL) are being reported. Timely diagnosis and management of MMF induced PCNSL can play
Externí odkaz:
https://doaj.org/article/70abf0e2efee470d82253840bd6ffee2
Publikováno v:
Case Reports in Hematology, Vol 2022 (2022)
Acute portal vein thrombosis represents a less common type of venous thromboembolism, even among the prothrombotic complications of coronavirus disease 2019 (COVID-19). Such complications are primarily reported during the active phase of infection. T
Externí odkaz:
https://doaj.org/article/61d5fceb0fd34443b1a9f69a44a297fd
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 10, Iss 4, Pp 353-357 (2020)
Characterized by bone marrow dysplasia and peripheral blood monocytosis, chronic myelomonocytic leukemia (CMML) is one of the most aggressive chronic leukemias and has a propensity for progression to acute myeloid leukemia (AML). Patients with newly
Externí odkaz:
https://doaj.org/article/ec6a3c6be862402e98e552ba8a3e534c
Autor:
P. Daniel Nicholas, Ian Garrahy
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 9, Iss 6, Pp 507-510 (2019)
Minimal Change Disease (MCD) is identified via renal biopsy as the etiology of nephrotic syndrome in a minority of adult cases; however, a significant proportion of these occurrences are accompanied by acute kidney injury (AKI). Risk factors for AKI
Externí odkaz:
https://doaj.org/article/ea599965e0da4f9e8a2b6a38c144f9ba
Autor:
P. Daniel Nicholas, Ian Garrahy
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 9, Iss 6, Pp 515-517 (2019)
Langerhans cell histiocytosis (LCH) is a rare malignancy most commonly characterized by histiocytic infiltration of bone. LCH lesions in the skull place the adjacent central nervous system (CNS) at risk for involvement, which can manifest as central
Externí odkaz:
https://doaj.org/article/dbd37fef3066488db13319088e937e1f
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 9, Iss 3, Pp 226-229 (2019)
AL amyloidosis is due to deposition of protein derived from immunoglobulin light chain fragments. It is a systemic disorder in which deposition of plasma proteins can adversely affect function of the heart, liver, kidneys, and peripheral nerves. Depo
Externí odkaz:
https://doaj.org/article/9d54816076db4f61a6e55b3ae0fb21b8
Publikováno v:
Case Reports in Cardiology, Vol 2020 (2020)
We report a case of a middle-aged female who presented with altered mental status, hypotension, and hypoglycemia and was diagnosed with secondary adrenal insufficiency. She was also found to have elevated troponin I on initial evaluation with diffuse
Externí odkaz:
https://doaj.org/article/cf32934a310847519c7327f1b6ad6e56
Autor:
Ian Garrahy, Daniel Forman
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 9, Iss 3, Pp 279-281 (2019)
Radiation recall dermatitis (RRD) is an inflammatory skin reaction that develops in a previously quiescent radiation field triggered most commonly by chemotherapy, particularly anthracyclines and taxanes. Radiation-recall dermatitis secondary to anti
Externí odkaz:
https://doaj.org/article/0a763260d0074566ae5773ec141b8d2f
Autor:
Olubunmi Oladunjoye, Ibiyemi Oke, Ian Garrahy, Adeolu Oladunjoye, Kyle Macaulay, Jeremy Ellis
Publikováno v:
Transformative Medicine. 2:6-9
Introduction: Immune checkpoint inhibitors including PD-1 inhibitors, were initially approved for the treatment of metastatic melanoma but are now increasingly being used for different types of solid organ malignancies. Despite the important clinical